Literature DB >> 30206643

Conflicts of interest in infection prevention and control research: no smoke without fire. A narrative review.

Mohamed Abbas1, Daniela Pires2,3, Alexandra Peters2, Chantal M Morel2, Samia Hurst4, Alison Holmes5, Hiroki Saito6, Benedetta Allegranzi6, Jean-Christophe Lucet7, Walter Zingg2, Stephan Harbarth2, Didier Pittet2.   

Abstract

Conflicts of interest (COIs) do occur in healthcare research, yet their impact on research in the field of infection prevention and control (IPC) is unknown. We conducted a narrative review aiming to identify examples of COIs in IPC research. In addition to well-known instances, we conducted PubMed and Google searches to identify and report case studies of COIs in IPC and antimicrobial resistance (AMR), which were chosen arbitrarily following consensus meetings, to illustrate different types of COIs. We also searched the Retraction Watch database and blog to systematically identify retracted IPC and/or infectious disease-related papers. Our review highlights COIs in academic research linked to ties between industry and physicians, journal editors, peer-reviewed journals' choice for publication, and guideline committees participants and authors. It explores how COIs can affect research and could be managed. We also present several selected case studies that involve (1) the chlorhexidine industry and how it has used marketing trials and key opinion leaders to promote off-label use of its products; (2) the copper industry and how reporting of its trials in IPC have furthered their agenda; (3) the influence of a company developing "closed infusion systems" for catheters and how this affects networks in low- and middle-income countries and guideline development; (4) potential perverse incentives hospitals may have in reporting healthcare-associated infection or AMR rates and how government intervention may restrict AMR research for fear of bad publicity and subsequent negative economic consequences. Finally, the analysis of reasons for the retraction of previously published papers highlights the fact that misconduct in research may have other motivations than financial gain, the most visible form of COIs. COIs occur in the field of research in general, and IPC and AMR are no exceptions. Their effects pervade all aspects of the research and publication processes. We believe that, in addition to improvements in management strategies of COIs, increased public funding should be available to decrease researchers' dependency on industry ties. Further research is needed on COIs and their management.

Entities:  

Keywords:  Antimicrobial resistance; Conflicts of interest; Industry sponsorship; Infection prevention and control; Integrity; Public-private partnerships; Retraction

Mesh:

Year:  2018        PMID: 30206643     DOI: 10.1007/s00134-018-5361-z

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  98 in total

1.  Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes.

Authors:  Isabelle Boutron; Susan Dutton; Philippe Ravaud; Douglas G Altman
Journal:  JAMA       Date:  2010-05-26       Impact factor: 56.272

2.  A randomised controlled trial evaluating the use of enteral nutritional supplements postoperatively in malnourished surgical patients.

Authors:  A H Beattie; A T Prach; J P Baxter; C R Pennington
Journal:  Gut       Date:  2000-06       Impact factor: 23.059

3.  Impact of switching from an open to a closed infusion system on rates of central line-associated bloodstream infection: a meta-analysis of time-sequence cohort studies in 4 countries.

Authors:  Dennis G Maki; Victor D Rosenthal; Reinaldo Salomao; Fabio Franzetti; Manuel Sigfrido Rangel-Frausto
Journal:  Infect Control Hosp Epidemiol       Date:  2010-12-01       Impact factor: 3.254

Review 4.  The burden of healthcare-associated infection in Australian hospitals: A systematic review of the literature.

Authors:  Brett G Mitchell; Ramon Z Shaban; Deborough MacBeth; Claudia-Jayne Wood; Philip L Russo
Journal:  Infect Dis Health       Date:  2017-08-15

5.  Understanding financial conflicts of interest.

Authors:  D F Thompson
Journal:  N Engl J Med       Date:  1993-08-19       Impact factor: 91.245

6.  Conflicts of interest at medical journals: the influence of industry-supported randomised trials on journal impact factors and revenue - cohort study.

Authors:  Andreas Lundh; Marija Barbateskovic; Asbjørn Hróbjartsson; Peter C Gøtzsche
Journal:  PLoS Med       Date:  2010-10-26       Impact factor: 11.069

7.  Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study.

Authors:  Karthikeyan K Kumarasamy; Mark A Toleman; Timothy R Walsh; Jay Bagaria; Fafhana Butt; Ravikumar Balakrishnan; Uma Chaudhary; Michel Doumith; Christian G Giske; Seema Irfan; Padma Krishnan; Anil V Kumar; Sunil Maharjan; Shazad Mushtaq; Tabassum Noorie; David L Paterson; Andrew Pearson; Claire Perry; Rachel Pike; Bhargavi Rao; Ujjwayini Ray; Jayanta B Sarma; Madhu Sharma; Elizabeth Sheridan; Mandayam A Thirunarayan; Jane Turton; Supriya Upadhyay; Marina Warner; William Welfare; David M Livermore; Neil Woodford
Journal:  Lancet Infect Dis       Date:  2010-08-10       Impact factor: 25.071

Review 8.  Antimicrobial surfaces to prevent healthcare-associated infections: a systematic review.

Authors:  M P Muller; C MacDougall; M Lim
Journal:  J Hosp Infect       Date:  2015-10-03       Impact factor: 3.926

9.  How frequently do the results from completed US clinical trials enter the public domain?--A statistical analysis of the ClinicalTrials.gov database.

Authors:  Hiroki Saito; Christopher J Gill
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

10.  German medical students' exposure and attitudes toward pharmaceutical promotion: a cross-sectional survey.

Authors:  Kristine Jahnke; Marcel Stephan Kremer; Carsten Oliver Schmidt; Michael M Kochen; Jean-François Chenot
Journal:  GMS Z Med Ausbild       Date:  2014-08-15
View more
  5 in total

1.  Focus on ethics of admission and discharge policies and conflicts of interest.

Authors:  Sharon Einav; Dominique D Benoit
Journal:  Intensive Care Med       Date:  2019-07-02       Impact factor: 17.440

2.  Clarification of errors in Abbas et al.'s conflict of interest narrative review.

Authors:  Robert A Weinstein
Journal:  Intensive Care Med       Date:  2018-11-26       Impact factor: 17.440

3.  Recommendations on Off-Label Drug Use in Pediatric Guidelines.

Authors:  Min Meng; Qi Zhou; Wenjuan Lei; Min Tian; Ping Wang; Yunlan Liu; Yajia Sun; Yaolong Chen; Qiu Li
Journal:  Front Pharmacol       Date:  2022-06-09       Impact factor: 5.988

4.  Infection prevention requirements for the medical care of immunosuppressed patients: recommendations of the Commission for Hospital Hygiene and Infection Prevention (KRINKO) at the Robert Koch Institute.

Authors: 
Journal:  GMS Hyg Infect Control       Date:  2022-04-13

5. 

Authors: 
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-02       Impact factor: 1.513

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.